Veriheal

MARCH 1, 2022

The first legal psilocybin therapy program to take shape in America is slowly progressing in Oregon. Kate Brown conducts regularly scheduled monthly meetings with a goal of shaping the nation’s first Psilocybin therapy program. Oregon’s Psilocybin Therapy Program: Advisory Board Hard at Work. ” . .”

Therapy 98

Therapy Programs Microdosing Medicine 98

Cannabis Law Report

OCTOBER 4, 2021

In Attorney , Federal Law , Kathryn Tucker , Oregon , Psychedelics. Advanced Illness , Oregon Psilocybin Advisory Board , Oregon Psilocybin Services Act , Psilocybin , Psilocybin Therapy , Psychedelics , Right To Try. The provider of the therapy must be a licensed “facilitator” pursuant to the statute. September 30, 2021.

Therapy 52

Therapy Patients Law Clinical Trials 52

Cannabis Law Report

JUNE 9, 2023

. – The Medford Planning Commission voted to approve a psilocybin treatment facility during its meeting on Thursday, May 25. Shrooms Help Center will become the city’s first ever psilocybin treatment facility. It will contain six therapy […]

Treatment 52

Treatment Therapy 52

United Patients Group

JANUARY 30, 2023

The Benefits of Cannabis in the Treatment of Myasthenia Gravis Introduction Myasthenia gravis ( MG ) is a rare autoimmune disease that affects the nerves and muscles. Doctors usually treat MG with thymectomies, immunomodulating drugs, acetylcholinesterase inhibitors and IV immunoglobulin treatments. Could marijuana be the answer?

Treatment 120

Treatment Cannabinoids Blood Pressure THC 120

Cannabis Law Report

AUGUST 18, 2022

Smith , a partner with the firm and co-leader of the firm’s Life Sciences & Health Effects Team, will lead the practice, bringing together scientist-attorneys and experienced litigators to support clients that are driving innovation in mental health treatments. BUFFALO, N.Y. , Aug. Tweet this.

Therapy 52

Therapy Research and Development Pharmaceutical Treatment 52

Veriheal

JUNE 7, 2021

Always consult a physician before attempting alternative therapies. It turns out that this blissful drug, MDMA, has the potential to be used effectively as a treatment for certain conditions- some of which are in urgent need of effective medical assistance. . What is MDMA?

Therapy 85

Therapy Treatment Conditions Clinical Trials 85

Cannabis Law Report

MARCH 22, 2023

When psychedelic therapies begin to gain regulatory approval, they will need to be incorporated into the medical billing and coding system in a way that ensures equitable patient access, say experts.

Therapy 52

Therapy Treatment Conditions Access 52

Cannabis Law Report

NOVEMBER 17, 2022

The Finnish Medicines Agency (Fimea) has granted Clairvoyant Therapeutics, a Canadian drug company, permission to study the effects of psychedelic drug therapies for the treatment of alcohol addiction. Fimea’s approval marks the first time psychedelic drug trials will be carried out in Finland.

Therapy 52

Therapy Clinical Trials Treatment Medicine 52

Veriheal

MARCH 12, 2024

The number of studies and research surrounding psychedelics is also growing at a rapid pace, demonstrating the benefits of substances like psilocybin (magic mushrooms), DMT, and ayahuasca as treatments for depression, anxiety, post-traumatic stress disorder (PTSD), and more.

Therapy 109

Therapy Decriminalization Treatment Topical 109

Cannabis Law Report

MARCH 29, 2023

. (“Numinus” or the “Company”) (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that it has launched the Numinus Certification Pathway – a collection of psychedelic-assisted therapy (“PAT”) training courses (..)

Therapy 52

Therapy Programs Collective Treatment 52

Cannabis Law Report

OCTOBER 14, 2021

International Summit on Psychedelic Therapies for Mental Illness. Why do we need psychedelic-assisted therapies? The current state of mental health globally, existing treatments and the need for innovation. The current state of mental health globally, existing treatments and the need for innovation. Session 1. Session 7.

Therapy 105

Therapy Medicine Treatment Programs 105

Cannabis Law Report

JUNE 16, 2021

We are excited to explore the potential of emergent psychedelic therapies. Patients deserve more options, and to be assured of the safety and efficacy of their treatments; similarly, physicians deserve answers and are a critical partner in the development of this new therapeutic class,” says Erin Prosk , President of Santé.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Cannabis Law Report

SEPTEMBER 30, 2022

Ahead of federal approval, Connecticut seeks to lay the groundwork for psychedelic treatments in the state. Connecticut is slated to provide legal, state-supported MDMA and psilocybin therapy as early as next year.

Therapy 52

Therapy Legalization Food Treatment 52

Canna Law Blog

NOVEMBER 10, 2020

I was talking to another lawyer about last week’s vote by Oregonians to legalize psilocybin therapy here in the state. Public Law 115-176 (“Right to Try”) is a federal law enacted in 2018 that creates a uniform system for terminal patients seeking access to investigational treatments. It’s quite restrictive.

Therapy 78

Therapy Clinical Trials Decriminalization Patients 78

Veriheal

SEPTEMBER 28, 2020

However, recently the CDC has been hosting meetings with medical cannabis patients as part of a larger project that includes gaining insight from those utilizing alternative treatments to manage pain. Cannabinoid Therapies Offer Hope Without Significant Risk. This is for good reasoning.

Treatment 98

Treatment Chronic Pain Therapy Cannabinoids 98

Cannabis Law Report

SEPTEMBER 28, 2021

In this article, you will find some of the best alternatives to opioids for treating serious and chronic pain, ranging from organic CBD oil tinctures and other CBD products, physical therapy, and acupuncture to injections, nerve blocks, and radio waves. Acupuncture is one of the safest alternative forms of treatment for chronic pain.

Treatment 52

Treatment Chronic Pain Therapy Tincture 52

Cannabis Law Report

MAY 19, 2022

When Thomas Hartle indulges in a session of psilocybin treatment, the end-of-life anxiety, distractions and noises associated with his terminal colon cancer go away. “Before the treatment, it’s like you’re sitting in your car. There must have been a lot of treatments done beforehand so the application is solid.”

Therapy 52

Therapy Patients Treatment Clinical Trials 52

Cannabis Law Report

NOVEMBER 10, 2022

AN OPEN LETTER TO THE PRIME MINISTER Vanessa Bortolin Delivers a Letter to the Prime Minister Anthony Albanese, Telling The Story of Her Husband’s Suicide and Requesting His Assistance In Creating A New Treatment Pathway For People With Treatment Resistant Depression By Allowing Limited Access To Psychedelic-Assisted Therapy On […].

Treatment 52

Treatment Medicine Therapy Access 52

Cannabis Law Report

FEBRUARY 24, 2022

Canada recently amended its Controlled Drugs and Substances Act (CDSA) to allow for psilocybin and MDMA therapy in limited circumstances. Subsection 56(1) of the CDSA will exempt medical providers from enforcement of the CDSA when providing psilocybin and MDMA treatment to patients suffering serious or terminal health conditions.

Therapy 52

Therapy Access Clinical Trials Treatment 52

The Cannigma

JUNE 2, 2023

The government remains steadfast in its commitment to maintaining strict drug laws to ensure public safety. The law unequivocally prohibits the possession, consumption, importation, and trafficking of cannabis. Law enforcement agencies in Singapore actively combat drug offenses. Is weed legal in Singapore?

Law 52

Law Research and Development Consumption Therapy 52

Cannabis Law Report

OCTOBER 20, 2021

International Summit on Psychedelic Therapies for Mental Illness 17-20 November 2021. It is for anyone with an interest in the topic and who is considering further development of their current therapeutic skills or who are eager to gain a detailed understanding of psychedelic-assisted psychotherapy for the treatment of mental illness.

Therapy 52

Therapy Medicine Topical Events 52

Cannabis Law Report

JULY 9, 2021

The state of the law on psychedelic substances is in flux. Not only are more and more jurisdictions decriminalizing the use of psychedelics for recreational purposes, but it appears that psychedelic substances are the new horizon for the treatment of severe psychological disorders and other ailments. Published Via JD Supra.

Law 105

Law Therapy Clinical Trials Research and Development 105

Canna Care Docs

AUGUST 9, 2022

Thanks to a new Virginia law that went into effect on July 1, the registration process for medical cannabis patients is now quicker and less of a burden. Medical providers may recommend medical cannabis or cannabinoid-based therapies for any condition they feel will benefit from these treatments. Virginia is different, however.

Law 105

Law Patients Legislation Conditions 105

Canna Law Blog

NOVEMBER 1, 2021

The Physician Self-Referral Law, commonly referred to as the Stark law (42 U.S.C. 1395nn), is one of several federal fraud and abuse laws. While the two laws may seem similar at first, they have very different rules and penalties. The Stark law has civil penalties, while the AKS has civil and criminal penalties.

Law 87

Law Therapy Treatment Programs 87

Cannabis Law Report

MAY 4, 2022

Connecticut lawmakers sent the governor a large-scale budget bill on Tuesday that includes provisions to set the state up to provide certain patients with access to psychedelic-assisted treatment using substances like MDMA and psilocybin. Connecticut Lawmakers Send Psychedelic Treatment Program Proposal To Governor As Part Of Budget Bill.

Treatment 52

Treatment Programs Therapy Access 52

Cannabis Law Report

JULY 1, 2021

As Curaleaf International ‘s subsidiary Adven GmbH seeks to advance its medical cannabis products in Germany, it has teamed up with an Italian pharmaceutical company, Zambon Spa , with whom it will provide medical cannabis treatments for patients, with an initial focus on neurological therapies.

Treatment 93

Treatment Pharmaceutical Therapy Oil 93

Cannabis Law Report

MARCH 11, 2023

In 2020, Health Canada granted Hartle an exemption to the Controlled Drugs and Substances Act to use psilocybin therapy for one year. The psychedelic-assisted therapy helped ease Hartle’s anxieties about dying. “It He was the first person in Canada to receive an exemption.

Treatment 52

Treatment Therapy 52

Cannabis Law Report

JULY 1, 2021

The Project on Psychedelics Law and Regulation (POPLAR). The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is engaged in a three-year initiative to examine the ethical, legal, and social implications of psychedelics research, commerce, and therapeutics. Background. The Project.

Law 59

Law Policy Research and Development Clinical Trials 59

Canna Law Blog

MAY 27, 2020

In August 2018, we wrote about the FDA approving a psilocybin trial for treatment-resistant depression. The post Oregon Psychedelics: Petition to Legalize Psilocybin for Therapy Moves Forward appeared first on Harris Bricken. We have been tracking the psilocybin movement for some time now.

Therapy 98

Therapy Legalization Decriminalization Pharmaceutical 98

Veriheal

NOVEMBER 9, 2023

Traditional treatments for these conditions often involve medication, physical therapy, or more invasive interventions like surgery. Refractory pain refers to pain resistant to traditional treatment approaches such as medication, physical therapy, or surgery. Fortunately, there is an alternative on the horizon.

Treatment 109

Treatment Therapy Research and Development THC 109

MMJ Recs

MARCH 28, 2024

Navigating the world of medical marijuana (MMJ) in Iowa can be a daunting task for patients seeking alternative treatments. With evolving laws and regulations, finding the right MMJ doctor and understanding the appointment process are crucial steps. Are you familiar with the qualifying conditions for MMJ treatment under Iowa law?

Patients 52

Patients Treatment Research and Development Therapy 52

Cannabis Law Report

MAY 26, 2022

NEO: AWKN ) (OTCQB: AWKNF) (FSE: 954) (‘Awakn’), a biotechnology company, researching, developing, and commercializing therapeutics to treat addiction, announced today the filing of a Patent Cooperation Treaty (PCT) application for the treatment of behavioral addictions with ketamine and ketamine-assisted psychotherapy.

Treatment 52

Treatment Research and Development Therapy Data 52

MMJ Recs

JANUARY 20, 2024

With a nuanced approach to medical marijuana laws, the state has embarked on a journey that seeks to balance patient well-being, regulatory oversight, and societal concerns. Let’s take a closer look at medical marijuana laws in Maryland and how they affect those in need of MMJ treatment!

Law 52

Law Marijuana Patients Chronic Pain 52

Cannabis Law Report

OCTOBER 21, 2021

(NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (‘Awakn’), a biotechnology company developing and delivering psychedelic therapeutics (medicines and therapies) to treat addiction, announced today that Awakn Clinics Bristol has received Care Quality Commission’s (CQC) formal approval to begin treatments. and Oslo in Norway which was the first.

Treatment 52

Treatment Therapy Medicine 52

Cannabis Law Report

JULY 13, 2022

VANCOUVER, British Columbia, July 13, 2022 (GLOBE NEWSWIRE) — Optimi Health Corp. ( Our Supply Agreement with Bloom solidifies another key relationship for Optimi,” said CEO Bill Ciprick.

Therapy 52

Therapy Clinical Trials Microdosing Research and Development 52

NORML

MARCH 23, 2020

The National Organization for the Reform of Marijuana Laws wishes to reiterate its message that cannabis consumers and others beware of online misinformation surrounding the use of either whole-plant cannabis or CBD as a potential remedy for the COVID-19 virus.

CBD 343

CBD Therapy Treatment Packaging 343

Cannabis Law Report

SEPTEMBER 17, 2022

– September 15, 2022) – HealingMaps, an informative and trusted psychedelic therapy search site announced today the close of $1 Million USD in seed round funding from eight investors. Miami, Florida–(Newsfile Corp. The round was led by Phyto Partners along with Ambria Capital. ”

Therapy 52

Therapy Education Patients Treatment 52